Skip to content
Research Article Open access CC BY 3.0

Line Probe Assay as a Rapid Tool for Detection of MDRTB

Rajani Ranganath, G. S. Vijay Kumar, Veerabhadra Javali, Ravi Ranganath

Annual Research & Review in Biology · pp. 246–257 · Published 5 Oct 2013

10.9734/ARRB/2014/5650

Abstract

Aims: To evaluate genotypic Line Probe Assay (LPA) for rapid detection of Multidrug Resistant Tuberculosis (MDRTB) directly from sputum samples in comparison with Drug Susceptibility Testing (DST) on phenotypic MBBacT liquid media. Study Design: Data analysis from 86 Mycobacterium tuberculosis (MTB) strains was done using SPSS version 17. Place and Duration of Study: Department of Microbiology, JSS Medical College, Mysore, Karnataka, between January 2011 to January 2012. Methodology: MDRTB rate detected by LPA assay from 92 samples by noting the mutations in hot spot region of rpoB gene, katG and inhA regulatory region and compared with DST on MBBacT liquid media. Results: Out of 86 MTB isolates, resistant rates for Rifampicin (RIF) and Isoniazid (INH) were 41.8%, 39.53% by LPA and 45.34%, 55.81% by MBBacT. LPA assay showed sensitivity and specificity as 92.35%, 100% for RIF resistance detection and 70.83%, 100% for INH resistance detection, 94.74%, 100% for MDRTB detection compared to conventional DST results. Conclusion: This study showed that LPA has high detection rate for RIF resistance. However to improve the detection of INH resistance in MTB strains additional probes are to be included in LPA. LPA has good sensitivity and specificity for MDRTB detection with turnaround time of less than 48 hours.

LPA MDRTB RIF INH resistance.

References (19)

  1. 1 Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis [DOI]
  2. 2 Clinical Microbiology Procedures Handbook [DOI]
  3. 3 Tuberculosis Drug Resistance Mutation Database [DOI]
  4. 4 Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay [DOI]
  5. 5 Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South Africa [DOI]
  6. 6 GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis [DOI]
  7. 7 Use of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates [DOI]
  8. 8 Analysis for a Limited Number of Gene Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a High-Incidence Community [DOI]
  9. 9 Performance of the Genotype MTBDR Line Probe Assay for Detection of Resistance to Rifampin and Isoniazid in Strains of Mycobacterium tuberculosis with Low- and High-Level Resistance [DOI]
  10. 10 Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda [DOI]
  11. 11 High Prevalence of KatG Ser315Thr Substitution among Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Northwestern Russia, 1996 to 2001 [DOI]
  12. 12 Use of Genotype MTBDR Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Clinical Strains Isolated in Italy [DOI]
  13. 13 Validation of the GenoType® MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand [DOI]
  14. 14 Rapid Genotypic Detection of Rifampin- and Isoniazid-Resistant Mycobacterium tuberculosis Directly in Clinical Specimens [DOI]
  15. 15 An Integrated Approach to Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using Liquid Culture and Molecular Methods in Russia [DOI]
  16. 16 Comparison of line probe assay with liquid culture for rapid detection of multi-drug resistance in Mycobacterium tuberculosis.
  17. 17 Evaluation of a Commercial Probe Assay for Detection of Rifampin Resistance in Mycobacterium tuberculosis Directly from Respiratory and Nonrespiratory Clinical Samples [DOI]
  18. 18 Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility [DOI]
  19. 19 Mycobacterium tuberculosisand Rifampin Resistance, United Kingdom [DOI]

Cited by 7

Anti-TB drug resistance in Tanga, Tanzania: A cross sectional facility-base prevalence among pulmonary TB patients.

A. Hoza, S. Mfinanga, B. König · Asian Pacific Journal of Tropical Medicine · 2015

Showing 4 of 7 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

39

Page views

0

PDF downloads

8

Outbound clicks

7

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.